Esperion Therapeutics Inc (ESPR) 3.18 USD (%)

Warning: The stock Esperion Therapeutics Inc has been delisted from NASDAQ market 1 week ago.

Esperion Therapeutics is a biopharmaceutical company focused on the development and commercialization of therapies to treat lipid disorders.

biotechnology medical-technology

This stock is no longer available on the market.

Momentum is clearly very favorable and suggests a sustained re-rating phase after a long period of underperformance. The recent trend shows a sharp acceleration in investor interest, which may signal an improvement in perceived commercial prospects, but the case remains speculative and sensitive to any execution disappointment.

Esperion Therapeutics Inc

Trend Analysis of Esperion Therapeutics Inc

Want to see the full analysis?